# Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery

> **NCT05486416** · PHASE3 · COMPLETED · sponsor: **Haisco-USA Pharmaceuticals, Inc.** · enrollment: 465 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05486416
- **Lead sponsor:** Haisco-USA Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-12
- **Primary completion:** 2024-07-23
- **Final completion:** 2024-07-23
- **Target enrollment:** 465 (ACTUAL)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486416, "Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05486416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*